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Prostate Cancer • Robotic assisted laparoscopic prostatec-
tomy • Lymphoma
We report a case of prostatic lymphoma of the Walden-
ström’s macroglobulinemia subtype in a 64-year-old gen-
tleman who underwent a robotic-assisted laparoscopic 
prostatectomy following lower urinary tract symptoms and 
high grade adenocarcinoma on transperineal prostate biop-
sy’s. Histopathological and immunohistochemistry analysis 
at the time of surgery was consistent with a CD5-negative 
small B-cell lymphoma. To our knowledge this is the first re-
ported prostatic lymphoma identified following robotic-as-
sisted laparoscopic prostatectomy and the first documented 
case of lymphoplasmacytic lymphoma involving prostate. 
Lymphoma of the prostate is an uncommon entity in sur-
gical practice and their diagnosis often poses considerable 
difficulty as they often mimic carcinoma. We discuss this 
rare diagnosis and review the literature for current consider-
ations and prognosis.
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The most common subtype of lymphoma appears to be 
diffuse large B-cell non-Hodgkin’s lymphoma (NHL). 
Currently, radical prostatectomy is considered the gold 
standard for local treatment of organ-confined prostate 
cancer. Nodal involvement can be challenging to detect 
prior to lymph node dissection as it is frequently micro-
scopic and therefore undetectable using existing imaging 
modalities. Consequently lymph node involvement is of-
ten neglected only to be discovered post-operatively by 
histopathological examination of the resected specimen.
Lymphoplasmacytic lymphoma (Waldenström mac-
roglobulinemia) is an exceptionally rare B-cell disorder 
secondary to the accumulation of clonally related lym-
phoplasmacytic cells in the bone marrow, with an inci-
dence of 3 cases per million yearly.
We report a 64-year-old gentleman who presented 
with lower urinary tract symptoms and to our knowledge 
is the first documented diagnosis of prostatic lymphoma 
following robotic-assisted laparoscopic prostatectomy.
Case Presentation
A 64-year-old gentleman was referred to the urology depart-
ment with obstructive lower urinary tract symptoms namely noc-
turia, increased daytime frequency and urgency with a PSA of 
11.06 ng/ml (normal 0–4 ng/ml). Review of his systems was nega-
tive and there was no family history of prostate cancer. On exami-
nation he had a soft abdomen and digital rectal exam demonstrated 
a 40 ml benign feeling prostate. An initial laboratory test revealed 
a hemoglobin of 102 g/dl (normal 13.5–17.5 g/dl), WBC of 7.0 × 
109/l (normal 3.5–10.5 × 109/l), platelet count of 253 × 109/l (nor-
Introduction
Adenocarcinoma of the prostate is still the most com-
mon histological subtype accounting for > 90% of cases, 
with lymphoma of the prostate accounting for < 1% [1]. 
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mal 150–450 × 109/l). Subsequent pre-biopsy MRI demonstrated 
a 25 × 13 mm area of ill-defined T2 hyperintense change in the an-
terior gland apex with a PI-RADS score 5/5 (fig. 1). Transperineal 
biopsy of the prostate confirmed the presence of Gleason 3 + 4 = 
7 adenocarcinoma of the prostate in 7/26 cores with a maximum 
core involvement of 90%. A bone scan was negative for metastatic 
bone disease. He therefore underwent a robotic-assisted laparo-
scopic prostatectomy (bilateral wide local excision plus bladder 
neck preservation plus pelvic lymph node dissection).
Histopathological Examination
A bilateral, multifocal microacinar type of prostatic adenocar-
cinoma was identified with a dominant tumor nodule of 33 mm 
at the anterior gland. The distal apical margin was negative for 
tumor involvement and no extra prostatic disease was identified. 
The lymph nodes showed effacement of the normal architecture 
by a diffuse infiltrate of small lymphoid cells. Seminal vesicles of 
the prostate gland demonstrated a patchy infiltrate by a monoto-
nous population of small B-cells showing similar morphological 
features to those noted in the lymph node. A final Gleason score of 
3 + 4 = 7 and stage of pT2c N0 MX is found. It was also necessary 
for further evaluation by immunohistochemistry.
Immunohistochemistry
Immunohistochemical staining showed the lymphoid infiltrate 
was positive for CD20 (fig. 2), CD79a and Bcl2. Staining for 
light chains showed kappa restricted expression. Negative stain-
ing for CD3, CD5, CD23, cyclin D1, CD10, Bcl6, CD21, TdT 
and CD138 is found. Staining for MIB-1 demonstrated a very low 
proliferation fraction (< 5%). Overall the features were those of a 
CD5-negative small B-cell lymphoma.
Bone Marrow Trephine Examination
A good core of hypercellular bone marrow (90% cellularity) 
showed a predominantly paratrabecular infiltrate of small lympho-
cytes together with plasmacytoid and plasma cells. The lympho-
cytes were CD79+, CD20+, Bcl2+, but negative for CD5, CD23 
and CD10. The admixed plasma cells were CD138+ with kappa 
light chain restriction but negative for CD56. There was little tri-
lineage hemopoietic reserve. The features were those of lymphop-
lasmacytic lymphoma extensively involving the bone marrow.
Molecular Studies
Molecular studies confirmed the presence of MYD88 muta-
tion.
Further Management
Final diagnosis was Gleason 7 adenocarcinoma of the prostate 
with an incidental additional diagnosis of CD5 negative B-cell 
lymphoplasmacytic lymphoma (Waldenström’s macroglobuline-
mia) identified in the prostate. This gentleman was subsequently 
commenced on rituximab and bendamustine.
Discussion
Lymphoplasmacytic lymphoma (Waldenström macro-
globulinemia) is a lymphoproliferative disorder belong-
ing to the NHL category characterized by proliferating 
lymphoplasmacytic components of bone marrow and the 
presence of monoclonal immunoglobulins (IgM). It is a 
Fig. 1. MRI prostate demonstrating a 25 × 13 mm area of ill-de-
fined T2 hypointense change in the anterior gland apex with a 
PI-RADS score 5/5.
Fig. 2. CD 20 positive lymphoid cells.
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rare disease accounting for < 2% of NHL [2]. Clinical 
presentation is frequently heterogeneous while signs and 
symptoms of organ infiltration can be demonstrated. De-
spite its indolent course, prompt treatment is necessary to 
avoid organ impairment.
Its discreet pathology means that incidental findings 
of NHL are not often recognized at the time of radical 
prostatectomy for prostate cancer. Lymphoma of the 
prostate is an uncommon entity in surgical practice. They 
have been demonstrated to account for < 1% of prostatic 
disease. Early studies by Terris et al. [1] reported 1,092 
prostatectomies of which only 0.8% of cases demon-
strated a lymphoma. They concluded that the manage-
ment of the majority of incidental hematological malig-
nancies can be expectant with only aggressive lymphoma 
subtypes needing radical therapy.
Larger studies by Weir et al. [3] which looked at 6,143 
patients revealed lymphocytic lymphoma in 0.3% of 
specimens. One patient presented with submandibular 
swelling and elevated WBC with the other patients all 
presenting with no overt features of lymphoma. More-
over similar to in our case, imagining studies failed to 
demonstrate any disease in the pelvis and the character-
istical features which are often typical of a lymphoma 
were not seen in the majority of cases. The important 
point to elaborate on here is that lymphoma can be easily 
missed if careful attention is not given.
Numerous case reports and series have reported good 
prognosis following the incidental diagnosis of hemato-
logical malignancies following radical prostatectomy. Di 
Meglio et al. [4] reported after 30 months there was no 
evidence of either lymphoma recurrence or of prostate 
cancer progression (undetectable serum PSA) in a patient 
diagnosed with stage IV lymphoma after chemotherapy 
treatment (EBVD regimen). Although uncommon, early 
detection of lymphoma after radical prostatectomy will 
allow optimal management.
In a more recent case report by Drinis et al. [5], they 
describe an incidental NHL diagnosed after radical pros-
tatectomy for a prostate adenocarcinoma. Lymphadenec-
tomy at the time revealed a low grade lymphoma. Five 
year follow-up demonstrated no disease progression for 
both his lymphoma and prostate adenocarcinoma.
Conclusion
Although rare, prostatic lymphoma can present much 
like a typical adenocarcinoma of the prostate. The litera-
ture suggests that lymphoma involving the prostate gen-
erally has a good prognosis yet management following 
radical prostatectomy varies with each subtype. This is 
certainly the first case of lymphoma involving the pros-
tate both at our hospital in over 1,150 robotic prostatec-
tomies now performed and in the literature. Moreover, to 
our knowledge this is the first documented case of lymp-
hoplasmacytic lymphoma involving prostate.
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